Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Joseph

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
The New England Journal of Medicine|November 7, 2022
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskAruna Das Pradhan, Robert J Glynn, Jean-Charles Fruchart, et al.
Nature Genetics|November 29, 2025
Author Correction: Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrumDavid S M Lee, Kathleen M Cardone, David Y Zhang, et al.
Nature Communications|July 10, 2023
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failureDanielle Rasooly, Gina M Peloso, Alexandre C Pereira, et al.
Nature Communications|November 14, 2022
Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failureMichael G Levin, Noah L Tsao, Pankhuri Singhal, et al.
Nature Genetics|November 1, 2025
An African ancestry-specific nonsense variant in CD36 is associated with a higher risk of dilated cardiomyopathyJennifer E Huffman, Liam Gaziano, Zeina R Al Sayed, et al.
Journal of the American Geriatrics Society|April 21, 2023
Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationaleJacob Joseph, Nicholas M Pajewski, Rowena J Dolor, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A <i>MUC5B</i> Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or MortalityAnurag Verma, Jessica Minnier, Emily S Wan, et al.
JAMA Internal Medicine|June 27, 2022
Association of Kidney Comorbidities and Acute Kidney Failure With Unfavorable Outcomes After COVID-19 in Individuals With the Sickle Cell TraitAnurag Verma, Jennifer E Huffman, Lina Gao, et al.
Nature Medicine|April 10, 2021
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19Liam Gaziano, Claudia Giambartolomei, Alexandre C Pereira, et al.
Science (New York, N.Y.)|July 18, 2024
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran ProgramAnurag Verma, Jennifer E Huffman, Alex Rodriguez, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
The New England Journal of Medicine|November 7, 2022
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskAruna Das Pradhan, Robert J Glynn, Jean-Charles Fruchart, et al.
Nature Genetics|November 29, 2025
Author Correction: Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrumDavid S M Lee, Kathleen M Cardone, David Y Zhang, et al.
Nature Communications|July 10, 2023
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failureDanielle Rasooly, Gina M Peloso, Alexandre C Pereira, et al.
Nature Communications|November 14, 2022
Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failureMichael G Levin, Noah L Tsao, Pankhuri Singhal, et al.
Nature Genetics|November 1, 2025
An African ancestry-specific nonsense variant in CD36 is associated with a higher risk of dilated cardiomyopathyJennifer E Huffman, Liam Gaziano, Zeina R Al Sayed, et al.
Journal of the American Geriatrics Society|April 21, 2023
Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationaleJacob Joseph, Nicholas M Pajewski, Rowena J Dolor, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A <i>MUC5B</i> Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or MortalityAnurag Verma, Jessica Minnier, Emily S Wan, et al.
JAMA Internal Medicine|June 27, 2022
Association of Kidney Comorbidities and Acute Kidney Failure With Unfavorable Outcomes After COVID-19 in Individuals With the Sickle Cell TraitAnurag Verma, Jennifer E Huffman, Lina Gao, et al.
Nature Medicine|April 10, 2021
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19Liam Gaziano, Claudia Giambartolomei, Alexandre C Pereira, et al.
Science (New York, N.Y.)|July 18, 2024
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran ProgramAnurag Verma, Jennifer E Huffman, Alex Rodriguez, et al.
Pageof 20